Rethinking Cancer: Inflammation, Infections, and Mitochondrial Insights with Mark Lintern

Dave Asprey

Apr 30, 2024

Episode description

Today's episode focuses on Cancer with a true expert, Mark Lintern. You'll learn about the surprising links between infections, inflammation, and our body's powerhouses - the mitochondria. This is a chance to arm yourself with cutting-edge theories that could change the way we treat cancer. Simple changes in treatment perspectives might be the key to unlocking new ways to tackle cancer and by the end of this episode, you'll have a fresh arsenal of knowledge to rethink cancer's causes and solutions. This is an eye-opening discussion that promises to transform the way we approach this formidable disease. 



Timestamp Highlights: 

(00:00:01) Introduction to a new theory about cancer 

(00:01:08) The interplay between mitochondrial dysfunction and genetic factors 

(00:02:08) Evaluating cancer from a citizen scientist's perspective 

(00:03:15) Challenging mainstream cancer narratives with personal research 

(00:07:49) How biases affect cancer research and therapy development 

(00:09:40) Exploring the Warburg effect in cancer metabolism 

(00:23:05) Investigating pathogens as a potential trigger for the Warburg effect 

(00:27:18) Fungal connections to chronic disease and cancer 

(00:35:32) How pathogens and inflammation contribute to cancer's growth 

(00:37:37) Importance of addressing inflammation and fungal infections in cancer 

(00:43:32) Estrogen's role in cancer promotion 

(00:47:10) The connection between methyl deficiency and cancer 

(00:49:17) Metformin's dual role in blood sugar regulation and antifungal activity 

(00:50:01) Wrapping up the conversation with final insights 

 

Sponsors: 

ARRC LED | For More Information Visit www.ARRCLED.COM 

EnVy | Upgrade your sleep and skin health now at www.enVyPillow.com, use code DAVE10 at checkout. 

 

Resources: 

Episode description

Today's episode focuses on Cancer with a true expert, Mark Lintern. You'll learn about the surprising links between infections, inflammation, and our body's powerhouses - the mitochondria. This is a chance to arm yourself with cutting-edge theories that could change the way we treat cancer. Simple changes in treatment perspectives might be the key to unlocking new ways to tackle cancer and by the end of this episode, you'll have a fresh arsenal of knowledge to rethink cancer's causes and solutions. This is an eye-opening discussion that promises to transform the way we approach this formidable disease. 



Timestamp Highlights: 

(00:00:01) Introduction to a new theory about cancer 

(00:01:08) The interplay between mitochondrial dysfunction and genetic factors 

(00:02:08) Evaluating cancer from a citizen scientist's perspective 

(00:03:15) Challenging mainstream cancer narratives with personal research 

(00:07:49) How biases affect cancer research and therapy development 

(00:09:40) Exploring the Warburg effect in cancer metabolism 

(00:23:05) Investigating pathogens as a potential trigger for the Warburg effect 

(00:27:18) Fungal connections to chronic disease and cancer 

(00:35:32) How pathogens and inflammation contribute to cancer's growth 

(00:37:37) Importance of addressing inflammation and fungal infections in cancer 

(00:43:32) Estrogen's role in cancer promotion 

(00:47:10) The connection between methyl deficiency and cancer 

(00:49:17) Metformin's dual role in blood sugar regulation and antifungal activity 

(00:50:01) Wrapping up the conversation with final insights 

 

Sponsors: 

ARRC LED | For More Information Visit www.ARRCLED.COM 

EnVy | Upgrade your sleep and skin health now at www.enVyPillow.com, use code DAVE10 at checkout. 

 

Resources: 

Mindsip insights from this episode:

Recognize pathogens' role in triggering the Warburg effect

Persistent intracellular pathogens, particularly fungi, can trigger and sustain the Warburg effect as a cellular defense mechanism, which may ultimately lead to cancer.

Understand cancer cell fuel adaptation to combat pathogens

A cancer cell's ability to switch between glucose, glutamine, and fat for fuel is actually driven by the intracellular fungal pathogen's ability to use all three sources.

Limit estrogen to reduce fungal growth and cancer risk

High estrogen levels may contribute to cancers like breast and prostate cancer because estrogen acts as a signaling molecule that encourages the growth and virulence of fungal pathogens.

Consider Fenbendazole to potentially reduce cancer risk

The pet deworming drug Fenbendazole, which has antifungal properties, is taken by some biohackers because it may dramatically reduce the likelihood of getting cancer.

Recognize antifungal properties in off-label cancer drugs

Many off-label drugs used to treat cancer, such as metformin, statins, and doxycycline, also possess direct antifungal properties.

Limit iron and lactic acid to combat fungal infections

During chronic inflammation, excess iron and lactic acid act as 'rocket fuel' for fungal pathogens while also suppressing local immune cells, facilitating cellular invasion.

Recognize pathogens in tumors to understand cancer complexity

Contrary to older beliefs, recent research found that fungal and bacterial pathogens exist intracellularly in every single cancer type studied.

Recognize Warburg effect as a symptom, not cancer's root cause

The Warburg effect, a metabolic switch seen in cancer cells, is likely a symptom of an underlying trigger rather than the root cause of cancer itself.

Challenge dominant genetic theory of cancer's validity

The dominant genetic theory of cancer is largely unproven and may only be capable of explaining two of the ten hallmarks of the disease.

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

DOWNLOAD THE APP

Unlock the wisdom of longevity

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius

Unlock the wisdom of longevity

© Mindsip 2025 – Made with ❤ in Vilnius